Skip to main content
Top
Published in: European Radiology 7/2016

01-07-2016 | Molecular Imaging

Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival

Authors: Adriano Massimiliano Priola, Sandro Massimo Priola, Maria Teresa Giraudo, Dario Gned, Alessandro Fornari, Bruno Ferrero, Lorena Ducco, Andrea Veltri

Published in: European Radiology | Issue 7/2016

Login to get access

Abstract

Objectives

To evaluate the usefulness of diffusion-weighted magnetic resonance for distinguishing thymomas according to WHO and Masaoka-Koga classifications and in predicting disease-free survival (DFS) by using the apparent diffusion coefficient (ADC).

Methods

Forty-one patients were grouped based on WHO (low-risk vs. high-risk) and Masaoka-Koga (early vs. advanced) classifications. For prognosis, seven patients with recurrence at follow-up were grouped separately from healthy subjects. Differences on ADC levels between groups were tested using Student-t testing. Logistic regression models and areas under the ROC curve (AUROC) were estimated.

Results

Mean ADC values were different between groups of WHO (low-risk = 1.58 ± 0.20 × 10-3mm2/sec; high-risk = 1.21 ± 0.23 × 10-3mm2/sec; p < 0.0001) and Masaoka-Koga (early = 1.43 ± 0.26 × 10-3mm2/sec; advanced = 1.31 ± 0.31 × 10-3mm2/sec; p = 0.016) classifications. Mean ADC of type-B3 (1.05 ± 0.17 × 10-3mm2/sec) was lower than type-B2 (1.32 ± 0.20 × 10-3mm2/sec; p = 0.023). AUROC in discriminating groups was 0.864 for WHO classification (cut-point = 1.309 × 10-3mm2/sec; accuracy = 78.1 %) and 0.730 for Masaoka-Koga classification (cut-point = 1.243 × 10-3mm2/sec; accuracy = 73.2 %). Logistic regression models and two-way ANOVA were significant for WHO classification (odds ratio[OR] = 0.93, p = 0.007; p < 0.001), but not for Masaoka-Koga classification (OR = 0.98, p = 0.31; p = 0.38). ADC levels were significantly associated with DFS recurrence rate being higher for patients with ADC ≤ 1.299 × 10-3mm2/sec (p = 0.001; AUROC, 0.834; accuracy = 78.0 %).

Conclusions

ADC helps to differentiate high-risk from low-risk thymomas and discriminates the more aggressive type-B3. Primary tumour ADC is a prognostic indicator of recurrence.

Key Points

• DW-MRI is useful in characterizing thymomas and in predicting disease-free survival.
• ADC can differentiate low-risk from high-risk thymomas based on different histological composition
The cutoff-ADC-value of 1.309 × 10 -3 mm 2 /sec is proposed as optimal cut-point for this differentiation
• The ADC ability in predicting Masaoka-Koga stage is uncertain and needs further validations
• ADC has prognostic value on disease-free survival and helps in stratification of risk
Literature
1.
go back to reference Priola AM, Priola SM, Cardinale L, Cataldi A, Fava C (2006) The anterior mediastinum: diseases. Radiol Med 111:312–342CrossRefPubMed Priola AM, Priola SM, Cardinale L, Cataldi A, Fava C (2006) The anterior mediastinum: diseases. Radiol Med 111:312–342CrossRefPubMed
3.
go back to reference Nishino M, Ashiku SK, Kocher ON, Thurer RL, Boiselle PM, Hatabu H (2006) The thymus: a comprehensive review. Radiographics 26:335–348CrossRefPubMed Nishino M, Ashiku SK, Kocher ON, Thurer RL, Boiselle PM, Hatabu H (2006) The thymus: a comprehensive review. Radiographics 26:335–348CrossRefPubMed
4.
go back to reference Henschke CI, Lee IJ, Wu N et al (2006) CT screening for lung cancer: prevalence and incidence of mediastinal masses. Radiology 239:586–590CrossRefPubMed Henschke CI, Lee IJ, Wu N et al (2006) CT screening for lung cancer: prevalence and incidence of mediastinal masses. Radiology 239:586–590CrossRefPubMed
5.
go back to reference Novello S, Fava C, Borasio P et al (2005) Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. Ann Oncol 16:1662–1666CrossRefPubMed Novello S, Fava C, Borasio P et al (2005) Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. Ann Oncol 16:1662–1666CrossRefPubMed
6.
go back to reference Priola AM, Priola SM, Giaj-Levra M et al (2013) Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. Clin Lung Cancer 14:139–148CrossRefPubMed Priola AM, Priola SM, Giaj-Levra M et al (2013) Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. Clin Lung Cancer 14:139–148CrossRefPubMed
7.
go back to reference Müller-Hermelink HK, Ströbel P, Zettl A et al (2004) Combined thymic epithelial tumours. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart (WHO classification of tumours series). IARC Press, Lyon, pp 196–198 Müller-Hermelink HK, Ströbel P, Zettl A et al (2004) Combined thymic epithelial tumours. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart (WHO classification of tumours series). IARC Press, Lyon, pp 196–198
8.
go back to reference Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492CrossRefPubMed Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492CrossRefPubMed
9.
go back to reference Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ (2004) Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 183:283–289CrossRefPubMed Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ (2004) Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 183:283–289CrossRefPubMed
10.
go back to reference Okuma Y, Hosomi Y, Watanabe K et al (2014) Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. BMC Cancer 14:349–357CrossRefPubMedPubMedCentral Okuma Y, Hosomi Y, Watanabe K et al (2014) Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. BMC Cancer 14:349–357CrossRefPubMedPubMedCentral
11.
go back to reference Priola AM, Priola SM (2014) Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol 69:e230–e245CrossRefPubMed Priola AM, Priola SM (2014) Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol 69:e230–e245CrossRefPubMed
12.
go back to reference Landwehr P, Schulte O, Lackner K (1999) MR imaging of the chest: mediastinum and chest wall. Eur Radiol 9:1737–1744CrossRefPubMed Landwehr P, Schulte O, Lackner K (1999) MR imaging of the chest: mediastinum and chest wall. Eur Radiol 9:1737–1744CrossRefPubMed
13.
go back to reference Priola SM, Priola AM, Cardinale L, Perotto F, Fava C (2006) The anterior mediastinum: anatomy and imaging procedures. Radiol Med 111:295–311CrossRefPubMed Priola SM, Priola AM, Cardinale L, Perotto F, Fava C (2006) The anterior mediastinum: anatomy and imaging procedures. Radiol Med 111:295–311CrossRefPubMed
14.
go back to reference Shin KE, Yi CA, Kim TS et al (2014) Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol 24:677–684CrossRefPubMed Shin KE, Yi CA, Kim TS et al (2014) Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol 24:677–684CrossRefPubMed
15.
go back to reference Gümüștaș S, Inan N, Sarisoy HT (2011) Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol 21:2255–2260CrossRefPubMed Gümüștaș S, Inan N, Sarisoy HT (2011) Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol 21:2255–2260CrossRefPubMed
16.
go back to reference Abdel Razek A, Soliman N, Elashery R (2012) Apparent diffusion coefficient values of mediastinal masses in children. Eur J Radiol 81:1311–1314CrossRefPubMed Abdel Razek A, Soliman N, Elashery R (2012) Apparent diffusion coefficient values of mediastinal masses in children. Eur J Radiol 81:1311–1314CrossRefPubMed
17.
go back to reference Abdel Razek A, Elmorsy A, Elshafey M, Elhadedy T, Hamza O (2009) Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Magn Reson Imaging 30:535–540CrossRef Abdel Razek A, Elmorsy A, Elshafey M, Elhadedy T, Hamza O (2009) Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Magn Reson Imaging 30:535–540CrossRef
18.
go back to reference Seki S, Koyama H, Ohno Y et al (2014) Diffusion-weighted MR imaging vs. multi-detector row-CT: direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 83:835–842CrossRefPubMed Seki S, Koyama H, Ohno Y et al (2014) Diffusion-weighted MR imaging vs. multi-detector row-CT: direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 83:835–842CrossRefPubMed
19.
go back to reference Abdel Razek AA, Khairy M, Nada N (2015) Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging. Radiology 273:268–275CrossRef Abdel Razek AA, Khairy M, Nada N (2015) Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging. Radiology 273:268–275CrossRef
20.
go back to reference Priola AM, Priola SM (2015) Usefulness of diffusion-weighted MR imaging in predicting Masaoka-Koga clinical staging of thymic epithelial tumors by using the apparent diffusion coefficient. Radiology 274:936–937CrossRefPubMed Priola AM, Priola SM (2015) Usefulness of diffusion-weighted MR imaging in predicting Masaoka-Koga clinical staging of thymic epithelial tumors by using the apparent diffusion coefficient. Radiology 274:936–937CrossRefPubMed
22.
go back to reference Zhang YD, Wang Q, Wu CJ (2015) The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer. Eur Radiol 25:994–1004CrossRefPubMed Zhang YD, Wang Q, Wu CJ (2015) The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer. Eur Radiol 25:994–1004CrossRefPubMed
23.
go back to reference Padhani AR, Guoying L, Mu-Koh D et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125CrossRefPubMedPubMedCentral Padhani AR, Guoying L, Mu-Koh D et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125CrossRefPubMedPubMedCentral
24.
go back to reference Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635CrossRefPubMed Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635CrossRefPubMed
25.
go back to reference Priola AM, Priola SM (2013) Influence of selected b values on ADC quantification in diffusion-weighted MRI. Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40:1108–1809CrossRefPubMed Priola AM, Priola SM (2013) Influence of selected b values on ADC quantification in diffusion-weighted MRI. Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40:1108–1809CrossRefPubMed
26.
go back to reference Priola AM, Priola SM, Giraudo MT et al (2015) Chemical-shift and diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative assessment. Investig Radiol 50:228–238CrossRef Priola AM, Priola SM, Giraudo MT et al (2015) Chemical-shift and diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative assessment. Investig Radiol 50:228–238CrossRef
27.
go back to reference Priola AM, Priola SM, Ciccone G et al (2015) Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift magnetic resonance imaging in adulthood: reliability of the chemical-shift ratio and signal-intensity index. Radiology 274:238–249CrossRefPubMed Priola AM, Priola SM, Ciccone G et al (2015) Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift magnetic resonance imaging in adulthood: reliability of the chemical-shift ratio and signal-intensity index. Radiology 274:238–249CrossRefPubMed
28.
go back to reference Inchingolo R, De Gaetano AM, Curione D et al (2015) Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol 25:1087–1096CrossRefPubMed Inchingolo R, De Gaetano AM, Curione D et al (2015) Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol 25:1087–1096CrossRefPubMed
29.
go back to reference Fischer MA, Nanz D, Hany T et al (2011) Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 21:246–255CrossRefPubMed Fischer MA, Nanz D, Hany T et al (2011) Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 21:246–255CrossRefPubMed
30.
go back to reference Priola AM, Galetto G, Priola SM (2014) Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders. Clin Imaging 38:771–784CrossRefPubMed Priola AM, Galetto G, Priola SM (2014) Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders. Clin Imaging 38:771–784CrossRefPubMed
31.
go back to reference Rieker RJ, Hoegel J, Morresi-Hauf A et al (2002) Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 98:900–906CrossRefPubMed Rieker RJ, Hoegel J, Morresi-Hauf A et al (2002) Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 98:900–906CrossRefPubMed
32.
go back to reference Schmidt H, Gatidis S, Schwenzer NF, Martirosian P (2015) Impact of measurement parameters on apparent diffusion coefficient quantification in diffusion-weighted-magnetic resonance imaging. Investig Radiol 50:46–56CrossRef Schmidt H, Gatidis S, Schwenzer NF, Martirosian P (2015) Impact of measurement parameters on apparent diffusion coefficient quantification in diffusion-weighted-magnetic resonance imaging. Investig Radiol 50:46–56CrossRef
33.
go back to reference Ackman JB (2014) A practical guide to nonvascular thoracic magnetic resonance imaging. J Thorac Imaging 29:17–29CrossRefPubMed Ackman JB (2014) A practical guide to nonvascular thoracic magnetic resonance imaging. J Thorac Imaging 29:17–29CrossRefPubMed
35.
go back to reference Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718CrossRefPubMed Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718CrossRefPubMed
36.
go back to reference Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC (2013) Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies. Eur J Cardiothorac Surg 43:1131–1139CrossRefPubMed Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC (2013) Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies. Eur J Cardiothorac Surg 43:1131–1139CrossRefPubMed
37.
go back to reference Hatakenaka M, Nakamura K, Yabuuchi U et al (2014) Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy. Jpn J Radiol 32:80–89CrossRefPubMed Hatakenaka M, Nakamura K, Yabuuchi U et al (2014) Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy. Jpn J Radiol 32:80–89CrossRefPubMed
39.
go back to reference Nakamura K, Joja I, Nagasaka T et al (2012) The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence. Gynecol Oncol 127:478–483CrossRefPubMed Nakamura K, Joja I, Nagasaka T et al (2012) The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence. Gynecol Oncol 127:478–483CrossRefPubMed
40.
go back to reference Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M (2014) 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med 28:257–262CrossRefPubMed Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M (2014) 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med 28:257–262CrossRefPubMed
41.
go back to reference Kaira K, Murakami H, Miura S et al (2011) 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med 25:247–253CrossRefPubMed Kaira K, Murakami H, Miura S et al (2011) 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med 25:247–253CrossRefPubMed
Metadata
Title
Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival
Authors
Adriano Massimiliano Priola
Sandro Massimo Priola
Maria Teresa Giraudo
Dario Gned
Alessandro Fornari
Bruno Ferrero
Lorena Ducco
Andrea Veltri
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2016
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-4031-6

Other articles of this Issue 7/2016

European Radiology 7/2016 Go to the issue